Cargando…
Vaccination inducing durable and robust antigen-specific Th1/Th17 immune responses contributes to prophylactic protection against Mycobacterium avium infection but is ineffective as an adjunct to antibiotic treatment in chronic disease
Mycobacterium avium complex (MAC) causing pulmonary disease in humanshas emerged worldwide. Thus, effective strategies simultaneously aiming to prevent MAC infection and accelerate therapeutic efficacy are required. To this end, subunit vaccine-induced protection against a well-defined virulent Myco...
Autores principales: | Lee, Ju Mi, Park, Jiyun, Reed, Steven G, Coler, Rhea N, Hong, Jung Joo, Kim, Lee-Han, Lee, Wonsik, Kwon, Kee Woong, Shin, Sung Jae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067471/ https://www.ncbi.nlm.nih.gov/pubmed/35499090 http://dx.doi.org/10.1080/21505594.2022.2068489 |
Ejemplares similares
-
Exacerbation of Mycobacterium avium pulmonary infection by comorbid allergic asthma is associated with diminished mycobacterium-specific Th17 responses
por: Bak, Yeeun, et al.
Publicado: (2021) -
Intracellular and in vivo activities of oxazolidinone drugs against Mycobacterium avium complex infection
por: Lee, Ju Mi, et al.
Publicado: (2023) -
Modulating macrophage function to reinforce host innate resistance against Mycobacterium avium complex infection
por: Park, Hyun-Eui, et al.
Publicado: (2022) -
Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model
por: Baldwin, Susan L., et al.
Publicado: (2021) -
Mycobacterium smegmatis Vaccine Vector Elicits CD4+ Th17 and CD8+ Tc17 T Cells With Therapeutic Potential to Infections With Mycobacterium avium
por: Kannan, Nisha, et al.
Publicado: (2020)